The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Am J Psychiatry 163:28-40, January 2006
doi: 10.1176/appi.ajp.163.1.28
© 2006 American Psychiatric Association
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Full Text (Publish Ahead of Print[PDF])
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Trivedi, M. H.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Trivedi, M. H.
Related Collections
* Depression
* Antidepressants
*Related Articles

Evaluation of Outcomes With Citalopram for Depression Using Measurement-Based Care in STAR*D: Implications for Clinical Practice

Madhukar H. Trivedi, M.D., A. John Rush, M.D., Stephen R. Wisniewski, Ph.D., Andrew A. Nierenberg, M.D., Diane Warden, Ph.D., M.B.A., Louise Ritz, M.B.A., Grayson Norquist, M.D., Robert H. Howland, M.D., Barry Lebowitz, Ph.D., Patrick J. McGrath, M.D., Kathy Shores-Wilson, Ph.D., Melanie M. Biggs, Ph.D., G. K. Balasubramani, Ph.D., and Maurizio Fava, M.D.

STAR*D Study Team

OBJECTIVE: Selective serotonin reuptake inhibitors (SSRIs) are widely used to treat depression, but the rates, timing, and baseline predictors of remission in "real world" patients are not established. The authors’ primary objectives in this study were to evaluate the effectiveness of citalopram, an SSRI, using measurement-based care in actual practice, and to identify predictors of symptom remission in outpatients with major depressive disorder. METHOD: This clinical study included outpatients with major depressive disorder who were treated in 23 psychiatric and 18 primary care "real world" settings. The patients received flexible doses of citalopram prescribed by clinicians for up to 14 weeks. The clinicians were assisted by a clinical research coordinator in the application of measurement-based care, which included the routine measurement of symptoms and side effects at each treatment visit and the use of a treatment manual that described when and how to modify medication doses based on these measures. Remission was defined as an exit score of ≤7 on the 17-item Hamilton Depression Rating Scale (HAM-D) (primary outcome) or a score of ≤5 on the 16-item Quick Inventory of Depressive Symptomatology, Self-Report (QIDS-SR) (secondary outcome). Response was defined as a reduction of ≥50% in baseline QIDS-SR score. RESULTS: Nearly 80% of the 2,876 outpatients in the analyzed sample had chronic or recurrent major depression; most also had a number of comorbid general medical and psychiatric conditions. The mean exit citalopram dose was 41.8 mg/day. Remission rates were 28% (HAM-D) and 33% (QIDS-SR). The response rate was 47% (QIDS-SR). Patients in primary and psychiatric care settings did not differ in remission or response rates. A substantial portion of participants who achieved either response or remission at study exit did so at or after 8 weeks of treatment. Participants who were Caucasian, female, employed, or had higher levels of education or income had higher HAM-D remission rates; longer index episodes, more concurrent psychiatric disorders (especially anxiety disorders or drug abuse), more general medical disorders, and lower baseline function and quality of life were associated with lower HAM-D remission rates. CONCLUSIONS: The response and remission rates in this highly generalizable sample with substantial axis I and axis III comorbidity closely resemble those seen in 8-week efficacy trials. The systematic use of easily implemented measurement-based care procedures may have assisted in achieving these results.


Related Articles:

Beyond Efficacy: The STAR*D Trial
Thomas R. Insel
Am J Psychiatry 2006 163: 5-7. [Full Text] [PDF]

In This Issue
Am J Psychiatry 2006 163: A34. [Full Text] [PDF]



This article has been cited by other articles:


Home page
 Journal of Pharmacy PracticeHome page
T. S. Hunter
L-methylfolate in the Therapeutic Management of Major Depressive Disorder
Journal of Pharmacy Practice, August 1, 2008; 21(4): 278 - 286.
[Abstract] [PDF]

Home page
 Am. J. PsychiatryHome page
C. Andreescu, B. H. Mulsant, P. R. Houck, E. M. Whyte, S. Mazumdar, A. Y. Dombrovski, B. G. Pollock, and C. F. Reynolds III
Empirically Derived Decision Trees for the Treatment of Late-Life Depression
Am J Psychiatry, July 1, 2008; 165(7): 855 - 862.
[Abstract] [Full Text] [PDF]

Home page
 Clin TrialsHome page
E. Frank, G. B Cassano, P. Rucci, A. Fagiolini, L. Maggi, H. C Kraemer, D. J Kupfer, B. Pollock, R. Bies, V. Nimgaonkar, et al.
Addressing the challenges of a cross-national investigation: lessons from the Pittsburgh-Pisa study of treatment-relevant phenotypes of unipolar depression
Clinical Trials, June 1, 2008; 5(3): 253 - 261.
[Abstract] [PDF]

Home page
 J PsychopharmacolHome page
I. Anderson, I. Ferrier, R. Baldwin, P. Cowen, L Howard, G Lewis, K Matthews, R. McAllister-Williams, R. Peveler, J Scott, et al.
Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2000 British Association for Psychopharmacology guidelines
J Psychopharmacol, June 1, 2008; 22(4): 343 - 396.
[Abstract] [PDF]

Home page
 CMAJHome page
A. J. Rush MD
Developing the evidence for evidence-based practice
Can. Med. Assoc. J., May 6, 2008; 178(10): 1313 - 1315.
[Full Text] [PDF]

Home page
 Am. J. PsychiatryHome page
J. C. Nelson
Anxious Depression and Response to Treatment
Am J Psychiatry, March 1, 2008; 165(3): 297 - 299.
[Full Text] [PDF]

Home page
 Am. J. PsychiatryHome page
M. Fava, A. J. Rush, J. E. Alpert, G. K. Balasubramani, S. R. Wisniewski, C. N. Carmin, M. M. Biggs, S. Zisook, A. Leuchter, R. Howland, et al.
Difference in Treatment Outcome in Outpatients With Anxious Versus Nonanxious Depression: A STAR*D Report
Am J Psychiatry, March 1, 2008; 165(3): 342 - 351.
[Abstract] [Full Text] [PDF]

Home page
 Am J Health Syst PharmHome page
J. Caballero, G. Souffrant, and E. Heffernan
Development and outcomes of a psychiatric pharmacy clinic for indigent patients
Am. J. Health Syst. Pharm., February 1, 2008; 65(3): 229 - 233.
[Abstract] [Full Text] [PDF]

Home page
 FocusHome page
C. B. Nemeroff
Recent Findings in the Pathophysiology of Depression
Focus, January 1, 2008; 6(1): 3 - 14.
[Full Text] [PDF]

Home page
 AJGPHome page
F. A. Kozel, M. H. Trivedi, S. R. Wisniewski, S. Miyahara, M. M. Husain, M. Fava, B. Lebowitz, S. Zisook, and A. J. Rush
Treatment Outcomes for Older Depressed Patients With Earlier Versus Late Onset of First Depressive Episode: A Sequenced Treatment Alternatives to Relieve Depression (STAR*D) Report
Am J Geriatr Psychiatry, January 1, 2008; 16(1): 58 - 64.
[Abstract] [Full Text] [PDF]

Home page
 FocusHome page
P. Clayton and T. Auster
Strategies for the Prevention and Treatment of Suicidal Behavior
Focus, January 1, 2008; 6(1): 15 - 21.
[Abstract] [Full Text] [PDF]

Home page
 FocusHome page
Bibliography for Major Depressive Disorder and Suicide
Focus, January 1, 2008; 6(1): 58 - 62.
[Full Text] [PDF]

Home page
 FocusHome page
G. Laje, S. Paddock, H. Manji, A. J. Rush, A. F. Wilson, D. Charney, and F. J. McMahon
Genetic Markers of Suicidal Ideation Emerging During Citalopram Treatment of Major Depression
Focus, January 1, 2008; 6(1): 69 - 79.
[Abstract] [Full Text] [PDF]

Home page
 FocusHome page
M. E. Thase, E. S. Friedman, M. M. Biggs, S. R. Wisniewski, M. H. Trivedi, J. F. Luther, M. Fava, A. A. Nierenberg, P. J. McGrath, D. Warden, et al.
Cognitive Therapy Versus Medication in Augmentation and Switch Strategies as Second-Step Treatments: A STAR*D Report
Focus, January 1, 2008; 6(1): 104 - 119.
[Abstract] [Full Text] [PDF]

Home page
 FocusHome page
A. J. Rush, M. H. Trivedi, S. R. Wisniewski, A. A. Nierenberg, J. W. Stewart, D. Warden, G. Niederehe, M. E. Thase, P. W. Lavori, B. D. Lebowitz, et al.
Acute and Longer-Term Outcomes in Depressed Outpatients Requiring One or Several Treatment Steps: A STAR*D Report
Focus, January 1, 2008; 6(1): 128 - 142.
[Abstract] [Full Text] [PDF]

Home page
 ANN INTERN MEDHome page
R. A. Mahmoud, G. J. Pandina, I. Turkoz, C. Kosik-Gonzalez, C. M. Canuso, M. J. Kujawa, and G. M. Gharabawi-Garibaldi
Risperidone for Treatment-Refractory Major Depressive Disorder: A Randomized Trial
Ann Intern Med, November 6, 2007; 147(9): 593 - 602.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. PsychiatryHome page
G. Laje, S. Paddock, H. Manji, A. J. Rush, A. F. Wilson, D. Charney, and F. J. McMahon
Genetic Markers of Suicidal Ideation Emerging During Citalopram Treatment of Major Depression
Am J Psychiatry, October 1, 2007; 164(10): 1530 - 1538.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. PsychiatryHome page
S. Zisook, I. Lesser, J. W. Stewart, S. R. Wisniewski, G.K. Balasubramani, M. Fava, W. S. Gilmer, T. R. Dresselhaus, M. E. Thase, A. A. Nierenberg, et al.
Effect of Age at Onset on the Course of Major Depressive Disorder
Am J Psychiatry, October 1, 2007; 164(10): 1539 - 1546.
[Abstract] [Full Text] [PDF]

Home page
 Psychosom. Med.Home page
J. A. Blumenthal, M. A. Babyak, P. M. Doraiswamy, L. Watkins, B. M. Hoffman, K. A. Barbour, S. Herman, W. E. Craighead, A. L. Brosse, R. Waugh, et al.
Exercise and Pharmacotherapy in the Treatment of Major Depressive Disorder
Psychosom Med, September 1, 2007; 69(7): 587 - 596.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. PsychiatryHome page
M. A. Badaracco
Keeping Our Depressed Patients in the Right Treatment Long Enough for Them to Get Better: Some Hopeful Findings
Am J Psychiatry, August 1, 2007; 164(8): 1136 - 1139.
[Full Text] [PDF]

Home page
 Am. J. PsychiatryHome page
S. Paddock, G. Laje, D. Charney, A. J. Rush, A. F. Wilson, A. J.M. Sorant, R. Lipsky, S. R. Wisniewski, H. Manji, and F. J. McMahon
Association of GRIK4 With Outcome of Antidepressant Treatment in the STAR*D Cohort
Am J Psychiatry, August 1, 2007; 164(8): 1181 - 1188.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. PsychiatryHome page
D. Warden, M. H. Trivedi, S. R. Wisniewski, L. Davis, A. A. Nierenberg, B. N. Gaynes, S. Zisook, S. D. Hollon, G.K. Balasubramani, R. Howland, et al.
Predictors of Attrition During Initial (Citalopram) Treatment for Depression: A STAR*D Report
Am J Psychiatry, August 1, 2007; 164(8): 1189 - 1197.
[Abstract] [Full Text] [PDF]

Home page
 AJGPHome page
P. Gorwood, E. Weiller, O. Lemming, and C. Katona
Escitalopram Prevents Relapse in Older Patients With Major Depressive Disorder
Am J Geriatr Psychiatry, July 1, 2007; 15(7): 581 - 593.
[Abstract] [Full Text] [PDF]

Home page
 Arch Gen PsychiatryHome page
X.-Z. Hu, A. J. Rush, D. Charney, A. F. Wilson, A. J. M. Sorant, G. J. Papanicolaou, M. Fava, M. H. Trivedi, S. R. Wisniewski, G. Laje, et al.
Association Between a Functional Serotonin Transporter Promoter Polymorphism and Citalopram Treatment in Adult Outpatients With Major Depression
Arch Gen Psychiatry, July 1, 2007; 64(7): 783 - 792.
[Abstract] [Full Text] [PDF]

Home page
 J PsychopharmacolHome page
D. Nutt, K. Demyttenaere, Z. Janka, T. Aarre, M. Bourin, P. L. Canonico, J. L. Carrasco, and S. Stahl
The other face of depression, reduced positive affect: the role of catecholamines in causation and cure
J Psychopharmacol, July 1, 2007; 21(5): 461 - 471.
[Abstract] [PDF]

Home page
 Arch Gen PsychiatryHome page
R. Cooper-Kazaz, J. T. Apter, R. Cohen, L. Karagichev, S. Muhammed-Moussa, D. Grupper, T. Drori, M. E. Newman, H. A. Sackeim, B. Glaser, et al.
Combined Treatment With Sertraline and Liothyronine in Major Depression: A Randomized, Double-blind, Placebo-Controlled Trial
Arch Gen Psychiatry, June 1, 2007; 64(6): 679 - 688.
[Abstract] [Full Text] [PDF]

Home page
 Arch Gen PsychiatryHome page
R. H. Perlis, S. Purcell, M. Fava, J. Fagerness, A. J. Rush, M. H. Trivedi, and J. W. Smoller
Association Between Treatment-Emergent Suicidal Ideation With Citalopram and Polymorphisms Near Cyclic Adenosine Monophosphate Response Element Binding Protein in the STAR*D Study
Arch Gen Psychiatry, June 1, 2007; 64(6): 689 - 697.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. PsychiatryHome page
M. E. Thase, E. S. Friedman, M. M. Biggs, S. R. Wisniewski, M. H. Trivedi, J. F. Luther, M. Fava, A. A. Nierenberg, P. J. McGrath, D. Warden, et al.
Cognitive Therapy Versus Medication in Augmentation and Switch Strategies as Second-Step Treatments: A STAR*D Report
Am J Psychiatry, May 1, 2007; 164(5): 739 - 752.
[Abstract] [Full Text] [PDF]

Home page
 Br. J. PsychiatryHome page
R. Toomey, H. K. Kang, J. Karlinsky, D. G. Baker, J. J. Vasterling, R. Alpern, D. J. Reda, W. G. Henderson, F. M. Murphy, and S. A. Eisen
Mental health of US Gulf War veterans 10 years after the war
The British Journal of Psychiatry, May 1, 2007; 190(5): 385 - 393.
[Abstract] [Full Text] [PDF]

Home page
 BMJHome page
R. H Perlis
Cytochrome P450 genotyping and antidepressants
BMJ, April 14, 2007; 334(7597): 759 - 759.
[Full Text] [PDF]

Home page
 Ann Fam MedHome page
B. N. Gaynes, A. J. Rush, M. H. Trivedi, S. R. Wisniewski, G. K. Balasubramani, D. C. Spencer, T. Petersen, M. Klinkman, D. Warden, L. Nicholas, et al.
Major Depression Symptoms in Primary Care and Psychiatric Care Settings: A Cross-Sectional Analysis
Ann. Fam. Med, March 1, 2007; 5(2): 126 - 134.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. PsychiatryHome page
A. J. Rush
STAR*D: What Have We Learned?
Am J Psychiatry, February 1, 2007; 164(2): 201 - 204.
[Full Text] [PDF]

Home page
 JAMAHome page
F. Lesperance, N. Frasure-Smith, D. Koszycki, M.-A. Laliberte, L. T. van Zyl, B. Baker, J. R. Swenson, K. Ghatavi, B. L. Abramson, P. Dorian, et al.
Effects of Citalopram and Interpersonal Psychotherapy on Depression in Patients With Coronary Artery Disease: The Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) Trial
JAMA, January 24, 2007; 297(4): 367 - 379.
[Abstract] [Full Text] [PDF]

Home page
 Journal of Pharmacy PracticeHome page
M. J. Ehret and B. Chavez
A Review of the STAR*D Trial
Journal of Pharmacy Practice, December 1, 2006; 19(6): 353 - 360.
[Abstract] [PDF]

Home page
 The Annals of PharmacotherapyHome page
Y. Chen, J. J Guo, S. Zhan, and N. C Patel
Treatment Effects of Antidepressants in Patients with Post-Stroke Depression: A Meta-Analysis
Ann. Pharmacother., December 1, 2006; 40(12): 2115 - 2122.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. PsychiatryHome page
J. C. Nelson
The STAR*D Study: A Four-Course Meal That Leaves Us Wanting More
Am J Psychiatry, November 1, 2006; 163(11): 1864 - 1866.
[Full Text] [PDF]

Home page
 Am. J. PsychiatryHome page
A. J. Rush, M. H. Trivedi, S. R. Wisniewski, A. A. Nierenberg, J. W. Stewart, D. Warden, G. Niederehe, M. E. Thase, P. W. Lavori, B. D. Lebowitz, et al.
Acute and Longer-Term Outcomes in Depressed Outpatients Requiring One or Several Treatment Steps: A STAR*D Report
Am J Psychiatry, November 1, 2006; 163(11): 1905 - 1917.
[Abstract] [Full Text] [PDF]

Home page
 FocusHome page
S. Zisook
Ask the Expert PSYCHOPHARMACOLOGY: MAJOR DEPRESSIVE DISORDER
Focus, September 1, 2006; 4(4): 484.
[Full Text] [PDF]

Home page
 FocusHome page
M. Valenstein
Keeping Our Eyes on STAR{star}D
Focus, September 1, 2006; 4(4): 522.
[Full Text] [PDF]

Home page
 FocusHome page
M. Menza
STAR{star}D: The Results Begin to Roll in
Focus, September 1, 2006; 4(4): 525.
[Full Text] [PDF]

Home page
 Am. J. PsychiatryHome page
M. Valenstein
Keeping Our Eyes on STAR*D
Am J Psychiatry, September 1, 2006; 163(9): 1484 - 1486.
[Full Text] [PDF]

Home page
 Am. J. PsychiatryHome page
F. V. deGruy III
A Note on the Partnership Between Psychiatry and Primary Care
Am J Psychiatry, September 1, 2006; 163(9): 1487 - 1489.
[Full Text] [PDF]

Home page
 Am. J. PsychiatryHome page
A. A. Nierenberg, M. Fava, M. H. Trivedi, S. R. Wisniewski, M. E. Thase, P. J. McGrath, J. E. Alpert, D. Warden, J. F. Luther, G. Niederehe, et al.
A Comparison of Lithium and T3 Augmentation Following Two Failed Medication Treatments for Depression: A STAR*D Report
Am J Psychiatry, September 1, 2006; 163(9): 1519 - 1530.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. PsychiatryHome page
P. J. McGrath, J. W. Stewart, M. Fava, M. H. Trivedi, S. R. Wisniewski, A. A. Nierenberg, M. E. Thase, L. Davis, M. M. Biggs, K. Shores-Wilson, et al.
Tranylcypromine Versus Venlafaxine Plus Mirtazapine Following Three Failed Antidepressant Medication Trials for Depression: A STAR*D Report
Am J Psychiatry, September 1, 2006; 163(9): 1531 - 1541.
[Abstract] [Full Text] [PDF]

Home page
 Psychosom. Med.Home page
K. W. Davidson, D. J. Kupfer, J. T. Bigger, R. M. Califf, R. M. Carney, J. C. Coyne, S. M. Czajkowski, E. Frank, N. Frasure-Smith, K. E. Freedland, et al.
Assessment and treatment of depression in patients with cardiovascular disease: national heart, lung, and blood institute working group report.
Psychosom Med, September 1, 2006; 68(5): 645 - 650.
[Abstract] [Full Text] [PDF]

Home page
 Br. J. PsychiatryHome page
A. C. M. Vergouwen
Initial rate of improvement in major depression
The British Journal of Psychiatry, August 1, 2006; 189(2): 189 - 189.
[Full Text] [PDF]

Home page
 Am. J. PsychiatryHome page
M. Menza
STAR*D: The Results Begin to Roll in
Am J Psychiatry, July 1, 2006; 163(7): 1123 - 1123.
[Full Text] [PDF]

Home page
 Am. J. PsychiatryHome page
M. Fava, A. J. Rush, S. R. Wisniewski, A. A. Nierenberg, J. E. Alpert, P. J. McGrath, M. E. Thase, D. Warden, M. Biggs, J. F. Luther, et al.
A Comparison of Mirtazapine and Nortriptyline Following Two Consecutive Failed Medication Treatments for Depressed Outpatients: A STAR*D Report
Am J Psychiatry, July 1, 2006; 163(7): 1161 - 1172.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. PsychiatryHome page
R. Hierholzer
Remission Rates for Depression in STAR*D Study
Am J Psychiatry, July 1, 2006; 163(7): 1293 - 1293.
[Full Text] [PDF]

Home page
 JAMAHome page
M. A. Whooley
Depression and cardiovascular disease: healing the broken-hearted.
JAMA, June 28, 2006; 295(24): 2874 - 2881.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
N. Sussman, S. C. Williams, L. Tebartz van Elst, D. Ebert, B. Hesslinger, A. J. Rush, M. H. Trivedi, S. R. Wisniewski, the STAR*D trial investigators, and D. R. Rubinow
Depression--augmentation or switch after initial SSRI treatment.
N. Engl. J. Med., June 15, 2006; 354(24): 2611 - 2613.
[Full Text] [PDF]